Paroxetin – Den stærke CYP2D6- inhibitor paroxetin øger den systemiske eksponering for lasofoxifen med 35%, hvilket ikke vurderes at være klinisk relevant.
Paroxetine - The strong CYP2D6 inhibitor paroxetine increased the systemic exposure of lasofoxifene by 35% which is not considered to be clinically meaningful.